Island Pharmaceuticals Limited (ASX:ILA)

Island Pharmaceuticals Revenue

In the fiscal year ending June 30, 2026, Island Pharmaceuticals had annual revenue of 282.66K AUD with 137.71% growth. Island Pharmaceuticals had revenue of 241.87K in the half year ending June 30, 2026, a decrease of -20.05%.

• Revenue: 282.66K
• Revenue Growth: +137.71%
• P/S Ratio: 444.94
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 125.76M

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2026	282.66K	163.75K	137.71%
Jun 30, 2025	118.91K	-1.14M	-90.57%
Jun 30, 2024	1.26M	-	-
Jun 30, 2023	-	-	-
Jun 30, 2022	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Sep 1, 2026

Data Sources Report a data error